ShockWave Medical Inc. (SWAV)
ShockWave Medical Statistics
Share Statistics
ShockWave Medical has 37.54M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 37.54M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 37.48M |
| Failed to Deliver (FTD) Shares | 163 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 47.49 and the forward PE ratio is null. ShockWave Medical's PEG ratio is -1.42.
| PE Ratio | 47.49 |
| Forward PE | n/a |
| PS Ratio | 9.58 |
| Forward PS | null |
| PB Ratio | 10.46 |
| P/FCF Ratio | 42.27 |
| PEG Ratio | -1.42 |
Enterprise Valuation
ShockWave Medical has an Enterprise Value (EV) of 7.44B.
| EV / Sales | 10.18 |
| EV / EBITDA | 42.17 |
| EV / EBIT | 37.93 |
| EV / FCF | 44.95 |
Financial Position
The company has a current ratio of 11.76, with a Debt / Equity ratio of 1.15.
| Current Ratio | 11.76 |
| Quick Ratio | 10.73 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 4.37 |
| Debt / FCF | 4.66 |
| Interest Coverage | 26.79 |
Financial Efficiency
Return on Equity is 22.03% and Return on Invested Capital is 9.75%.
| Return on Equity | 22.03% |
| Return on Assets | 9.4% |
| Return on Invested Capital | 9.75% |
| Revenue Per Employee | $497.43K |
| Profits Per Employee | $100.33K |
| Employee Count | 1,468 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.89 |
Taxes
| Income Tax | 27M |
| Effective Tax Rate | 15.49% |
Stock Price Statistics
The stock price has increased by 1.87% in the last 52 weeks. The beta is 0.88, so ShockWave Medical's price volatility has been higher than the market average.
| Beta | 0.88 |
| 52-Week Price Change | 1.87% |
| 50-Day Moving Average | 325.08 |
| 200-Day Moving Average | 240.56 |
| Relative Strength Index (RSI) | 77.62 |
| Average Volume (20 Days) | 1.25M |
Income Statement
In the last 12 months, ShockWave Medical had revenue of 730.23M and earned 147.28M in profits. Earnings per share was 4.01.
| Revenue | 730.23M |
| Gross Profit | 634.84M |
| Operating Income | 165.99M |
| Net Income | 147.28M |
| EBITDA | 176.35M |
| EBIT | 180.48M |
| Earnings Per Share (EPS) | 4.01 |
Balance Sheet
The company has 328.42M in cash and 770.61M in debt, giving a net cash position of -442.19M.
| Cash & Cash Equivalents | 328.42M |
| Total Debt | 770.61M |
| Net Cash | -442.19M |
| Retained Earnings | 110.47M |
| Total Assets | 1.64B |
| Working Capital | 1.18B |
Cash Flow
In the last 12 months, operating cash flow was 196.05M and capital expenditures -30.59M, giving a free cash flow of 165.46M.
| Operating Cash Flow | 196.05M |
| Capital Expenditures | -30.59M |
| Free Cash Flow | 165.46M |
| FCF Per Share | 4.51 |
Margins
Gross margin is 86.94%, with operating and profit margins of 22.73% and 20.17%.
| Gross Margin | 86.94% |
| Operating Margin | 22.73% |
| Pretax Margin | 23.87% |
| Profit Margin | 20.17% |
| EBITDA Margin | 24.15% |
| EBIT Margin | 22.73% |
| FCF Margin | 22.66% |
Dividends & Yields
SWAV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.11% |
| FCF Yield | 2.37% |
Analyst Forecast
Currently there are no analyst rating for SWAV.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 10.29 |
| Piotroski F-Score | 6 |